Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: Reproductive and hormonal risk factors for antinuclear antibodies (ANA) in a representative sample of U.S. women.

Authors: Parks, Christine G; Miller, Frederick W; Satoh, Minoru; Chan, Edward K L; Andrushchenko, Zhanna; Birnbaum, Linda S; Jusko, Todd A; Kissling, Grace E; Patel, Mehul D; Rose, Kathryn M; Weinberg, Clarice; Zeldin, Darryl C; Sandler, Dale P

Published In Cancer Epidemiol Biomarkers Prev, (2014 Nov)

Abstract: Autoantibodies are of growing interest in cancer research as potential biomarkers; yet, the determinants of autoimmunity are not well understood. Antinuclear antibodies (ANA) are common in the general population and are more prevalent in women and older adults. Here, we examined the relationship of ANA with reproductive and hormonal factors in a representative sample of U.S. women.We analyzed data on reproductive history and exogenous hormone use in relation to serum ANA in 2,037 females ages 12 years and older from the National Health and Nutrition Examination Survey (NHANES; 1999-2004). Estimated ANA prevalences were adjusted for sampling weights. Prevalence ORs (POR) and 95% confidence intervals (CI) were adjusted for age, race, and poverty-income ratio, and models were stratified by menopause status.In premenopausal women ages 20 years and older, ANA prevalence was associated with parity (P < 0.001; parous vs. nulliparous POR = 2.0; 95% CI, 1.2-3.4), but in parous women, ANA did not vary by number of births, age at first birth, years since last birth, or breastfeeding. In postmenopausal women, ANA prevalence was associated with an older age at menarche (P = 0.019; age 16-20 vs. 10-12 years POR = 3.0; 95% CI, 1.6-5.9), but not with parity. Oral contraceptives and estrogen therapy were not associated with a higher ANA prevalence.Childbearing (having had one or more births) may explain age-associated elevations in ANA prevalence seen in premenopausal women.These findings highlight the importance of considering reproductive history in studies of autoimmunity and cancer in women.

PubMed ID: 25086100 Exiting the NIEHS site

MeSH Terms: No MeSH terms associated with this publication

Back
to Top